This week Fred and Nick discuss the rising number of variants and the results of a study conducted by Clalit Health Services and Tel Aviv University reporting on real-world data that shows less effectiveness of the Pfizer vaccine against the South African variant
We review what that means and also discuss the reports of side effects from Astrazeneca of Thrombosis and Thrombocytopenia and the challenge we have of assessing risk vs reward

If you need additional help or support getting back to work and school safely reach contact us.